PHARMACEUTICAL TECHNOLOGY — Irbesartan Importer Profile
Pharmaceutical Importer · #19 buyer for Irbesartan · $1.0M import value · 69 shipments · DOMINICAN REPUBLIC · DGFT Verified
PHARMACEUTICAL TECHNOLOGY is the #19 importer of Irbesartan from India with $1.0M in import value and 69 verified shipments. PHARMACEUTICAL TECHNOLOGY holds a 0.9% market share in Irbesartan imports based in DOMINICAN REPUBLIC. The company sources from 1 verified supplier across 64 formulations shipped to 2 countries. Overall, PHARMACEUTICAL TECHNOLOGY imports 7 pharmaceutical products worth $9.8M across 4 therapeutic categories.
PHARMACEUTICAL TECHNOLOGY — Irbesartan Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Irbesartan to PHARMACEUTICAL TECHNOLOGY?
Verified from 69 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEPRO PHARMACEUTICALS PRIVATE LIMITED | $1.0M | 69 | 100.0% |
PHARMACEUTICAL TECHNOLOGY sources Irbesartan from 1 verified Indian supplier based on 69 customs records. The primary supplier is MEPRO PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does PHARMACEUTICAL TECHNOLOGY Compare to Nearest Irbesartan Importers?
Buyers ranked immediately above and below #19 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | APOTEX PTY. LTD. | AUSTRALIA | $1.1M | 22 | $49.7K |
| 17 | APOTEX PTY LTD | AUSTRALIA | $1.1M | 27 | $39.6K |
| 19 | PHARMACEUTICAL TECHNOLOGY ★ | DOMINICAN REPUBLIC | $982.7K | 63 | $15.6K |
| 9 | CSP MYLAN SAS AT CSP- LABO 274, | FRANCE | $950.0K | 19 | $50.0K |
| 18 | CSP VIATRIS SANTE AT CSP- LAB | FRANCE | $950.0K | 19 | $50.0K |
PHARMACEUTICAL TECHNOLOGY ranks #19 among 366 Irbesartan importers from India. Average shipment value of $15.6K compared to the market average of $68.3K. The closest competitors by value are APOTEX PTY. LTD. and APOTEX PTY LTD.
Where Does PHARMACEUTICAL TECHNOLOGY Import Irbesartan To?
Destination countries from 69 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPUBLIC | $636.6K | 45 | 62.1% |
| DOMINICAN REPULIC | $389.0K | 24 | 37.9% |
PHARMACEUTICAL TECHNOLOGY imports Irbesartan to 2 countries. The primary destination is DOMINICAN REPUBLIC receiving 62.1% of shipments worth $636.6K.
What Irbesartan Formulations Does PHARMACEUTICAL TECHNOLOGY Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS: KEOTAN PLUS 300+10+25 (Irbesartan 300mg,Amlodipine 10mgand Hydrochlorothiazide 25mg Tablets) Q | $71.9K | 3 |
| PHARMACEUTICAL PRODUCTS: KEOTAN PLUS 300+10+25 (Irbesartan 300mg,Amlodipine 10mgand Hydrochlorothiazide 25mg Tablets) q | $53.6K | 2 |
| PHARMACEUTICAL PRODUCTS: KEOTAN H 300/12.5 TP (Irbesartan & Hydrochlorothiazidetablets USP) QTY:12034x3x10'S | $49.3K | 3 |
| PHARMACEUTICAL PRODUCTS: KEOTAN 300 (Irbesartan Tablets USP 300mg.) (QTY:12028x3x10'S) | $46.9K | 1 |
| PHARMACEUTICAL PRODUCTS: KEOTAN H 300/25(IRBESARTAN & HYDROCHLOROTHIAZIDE TABLETS USP) (QTY: 10094X3X10'S)NOS | $43.0K | 1 |
| PHARMACEUTICAL PRODUCTS: KEOTAN H 300/25(Irbesartan & Hydrochlorothiazide tablets USP) QTY:10037x3x10'S | $42.2K | 1 |
| PHARMACEUTICAL PRODUCTS: KEOTAN PLUS 300/10/25 (IRBESARTANAMLODIPINE & HYDROCHLOROTHIAZIDE TABLETS ) (QTY: 8701X3X10'S)NOS | $40.5K | 1 |
| PHARMACEUTICAL PRODUCTS: KEOTAN H 300/12.5 TP Irbesartan & Hydrochlorothiazidetablets USP QTY:9073x3x10'S | $37.1K | 1 |
| PHARMACEUTICAL PRODUCTS: KEOTAN H 300/25Irbesartan,& Hydrochlorothiazide tablets USP QTY:8437x3x10'S | $35.8K | 1 |
| PHARMACEUTICAL PRODUCTS: KEOTAN H 300+25mg (Irbesartan and Hydrochlorothiazide Tablets USP) QTY:7680x3x10's | $32.0K | 1 |
PHARMACEUTICAL TECHNOLOGY imports 64 distinct Irbesartan formulations from India. The top formulation is PHARMACEUTICAL PRODUCTS: KEOTAN PLUS 300+10+25 (Irbesartan 3 with 3 shipments worth $71.9K.
Who Are the Top Buyers of Irbesartan from India and How Much Does PHARMACEUTICAL TECHNOLOGY Import?
India exported $25.0M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. PHARMACEUTICAL TECHNOLOGY imports $1.0M of this total, accounting for 0.9% of India's Irbesartan exports with 69 shipments from DOMINICAN REPUBLIC. This is verified from 69 customs shipment records covering 64 distinct formulations.
What Is the Average Order Value for PHARMACEUTICAL TECHNOLOGY's Irbesartan Imports?
PHARMACEUTICAL TECHNOLOGY's average Irbesartan order value is $14.9K per consignment, based on 69 shipments totaling $1.0M. PHARMACEUTICAL TECHNOLOGY is based in DOMINICAN REPUBLIC and ranks #19 among all Irbesartan importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Irbesartan to PHARMACEUTICAL TECHNOLOGY?
PHARMACEUTICAL TECHNOLOGY sources Irbesartan from 1 verified Indian supplier: MEPRO PHARMACEUTICALS PRIVATE LIMITED ($1.0M, 100.0%). This is based on 69 customs records.
How Does PHARMACEUTICAL TECHNOLOGY Compare to Other Irbesartan Importers?
PHARMACEUTICAL TECHNOLOGY ranks #19 among 366 Irbesartan importers from India with a 0.9% market share. The top 3 importers are MACLEODS PHARMA USA INC ($3.7M), APOTEX PTY LTD. ($2.9M), YUSEN LOGISTICS BENELUX BELGIUM ($2.6M). PHARMACEUTICAL TECHNOLOGY processed 69 shipments from DOMINICAN REPUBLIC.
What Other Cardiovascular Products Does PHARMACEUTICAL TECHNOLOGY Import?
PHARMACEUTICAL TECHNOLOGY also imports these cardiovascular products. Each links to the detailed product page.
About PHARMACEUTICAL TECHNOLOGY
PHARMACEUTICAL TECHNOLOGY imports 7 products worth $9.8M. Beyond Irbesartan, top products include Heparin, Enoxaparin, Syringe, Nifedipine, Miconazole. View the complete PHARMACEUTICAL TECHNOLOGY profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PHARMACEUTICAL TECHNOLOGY matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PHARMACEUTICAL TECHNOLOGY's capped import value divided by total capped export value for Irbesartan across all Indian exporters.
- 5.Verified Records: This page is backed by 69 individual customs records matching PHARMACEUTICAL TECHNOLOGY importing Irbesartan, covering 64 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Import Data for PHARMACEUTICAL TECHNOLOGY
Access order-level details, pricing data, supplier connections, and competitive analysis for PHARMACEUTICAL TECHNOLOGY's Irbesartan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PHARMACEUTICAL TECHNOLOGY
Full Company Profile →
7 products · $9.8M total trade · 4 categories
PHARMACEUTICAL TECHNOLOGY × Irbesartan
Verified from customs records
Company Overview
Top Products by PHARMACEUTICAL TECHNOLOGY
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PHARMACEUTICAL TECHNOLOGY.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current order-level data, contact TransData Nexus.